Back to Medicine Index

Linatab 5 mg

Tablet

Generic: Linagliptin

Incepta Pharmaceuticals Ltd.

Therapeutic Class: DPP-4 Inhibitor (Oral Antidiabetic)

Indications

Type 2 diabetes mellitus in adults, as an adjunct to diet and exercise, alone when metformin is unsuitable or in combination with other antidiabetic drugs including insulin.

Pharmacology

Linagliptin inhibits the enzyme DPP-4, raising the levels of the incretin hormones GLP-1 and GIP. This increases insulin release and lowers glucagon release in a glucose-dependent way. It is eliminated mainly through the bile, not the kidneys.

Dosage & Administration

Adult: 5 mg once daily, at any time of day, with or without food. No dose adjustment is needed in renal or hepatic impairment.

Side Effects

Nasopharyngitis, cough and hypoglycaemia when combined with a sulfonylurea or insulin. Pancreatitis, rash and blistering skin reaction (bullous pemphigoid) are rare.

Precautions & Warnings

Stop the drug and seek medical advice if severe persistent abdominal pain occurs. The dose of a sulfonylurea or insulin may need to be reduced. Use in pregnancy and breast-feeding is not recommended.

Contraindications

Hypersensitivity to linagliptin, type 1 diabetes and diabetic ketoacidosis.

Storage Conditions

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.